Tsingke Highlights AI-Driven CLDN18.2 Antibody Discovery at AIS 2026

Tsingke Highlights AI-Driven CLDN18.2 Antibody Discovery at AIS 2026

MONTPELLIER, France, July 8, 2026 /PRNewswire/ -- Tsingke, a provider of integrated life science research solutions, participated in the Antibody Industrial Symposium (AIS) 2026, one of Europe's leading conferences dedicated to therapeutic...

menu
menu